These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11603279)

  • 1. Endocannabinoid immune and vascular signaling.
    Stefano GB
    Acta Pharmacol Sin; 2000 Dec; 21(12):1071-81. PubMed ID: 11603279
    [No Abstract]   [Full Text] [Related]  

  • 2. The quest for a vascular endothelial cannabinoid receptor.
    Kunos G; Bátkai S; Offertáler L; Mo F; Liu J; Karcher J; Harvey-White J
    Chem Phys Lipids; 2002 Dec; 121(1-2):45-56. PubMed ID: 12505689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.
    Mechoulam R
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):93-9. PubMed ID: 12052029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids and vascular function.
    Hillard CJ
    J Pharmacol Exp Ther; 2000 Jul; 294(1):27-32. PubMed ID: 10871291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids and the gut.
    Pinto L; Capasso R; Di Carlo G; Izzo AA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):333-41. PubMed ID: 12052047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids: a new class of vasoactive substances.
    Randall MD; Kendall DA
    Trends Pharmacol Sci; 1998 Feb; 19(2):55-8. PubMed ID: 9550942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
    Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
    J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrograde signaling by endocannabinoids.
    Kreitzer AC; Regehr WG
    Curr Opin Neurobiol; 2002 Jun; 12(3):324-30. PubMed ID: 12049940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment on: localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity.
    Prieto D
    Eur Urol; 2010 Feb; 57(2):349. PubMed ID: 19147273
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative biology of the endocannabinoid system possible role in the immune response.
    Salzet M; Breton C; Bisogno T; Di Marzo V
    Eur J Biochem; 2000 Aug; 267(16):4917-27. PubMed ID: 10931174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges.
    Schmid HH; Schmid PC; Berdyshev EV
    Chem Phys Lipids; 2002 Dec; 121(1-2):111-34. PubMed ID: 12505695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids: new targets for drug development.
    Di Marzo ; Bisogno T; De Petrocellis L
    Curr Pharm Des; 2000 Sep; 6(13):1361-80. PubMed ID: 10903398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
    Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous cannabinoid signaling.
    Piomelli D; Beltramo M; Giuffrida A; Stella N
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):462-73. PubMed ID: 9974178
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery and isolation of anandamide and other endocannabinoids.
    Hanus LO
    Chem Biodivers; 2007 Aug; 4(8):1828-41. PubMed ID: 17712821
    [No Abstract]   [Full Text] [Related]  

  • 17. The endocannabinoid system as a target for therapeutic drugs.
    Piomelli D; Giuffrida A; Calignano A; Rodríguez de Fonseca F
    Trends Pharmacol Sci; 2000 Jun; 21(6):218-24. PubMed ID: 10838609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoids.
    Mechoulam R; Fride E; Di Marzo V
    Eur J Pharmacol; 1998 Oct; 359(1):1-18. PubMed ID: 9831287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1.
    Stefano GB; Bilfinger TV; Rialas CM; Deutsch DG
    Pharmacol Res; 2000 Oct; 42(4):317-22. PubMed ID: 10987990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids in the central nervous system--an overview.
    Fride E
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):221-33. PubMed ID: 12052038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.